Where are the phase IIb results for Bimatoprost?

[bornthisway]

Either it failed or it didn't. Just have to be patient. Like with Follicept, SM, and whatever else. Most things tend to end in failure generally though.

[rdawg]

We'll find out more information on Monday

what's happening on Monday?

this is a very intriguing situation here, The trials have been done for months but this company is very hush hush about this product, they have many other products on the pipeline so releasing failed results really wont hurt them much.

There must be something happening behind the scenes with this product.

[BiqqieSmalls]

We'll find out more information on Monday

[Keki]

I too believe is a positive news, you could have pushed a little more maybe, with a "so you are still developing the product" or somethign like that and see the reaction

[It's2014ComeOnAlready]

Regarding investor relations person saying the reason no results have been disclosed is because of the "complexity of bimatoprost." ...

Let's say it failed - what complexity is there to let everyone know that it failed for hair loss? There's nothing much to lose. It won't affect their stock price too much, as they have other very lucrative products lined up (DARPin etc) for the future. They're also a very valuable company, one bad apple doesn't spoil the whole lot.

Let's say it succeeded - Bimatoprost is now able to be legally produced by other companies. For other uses, yes. However, they have been trialling the drug at higher concentration, but it is nonetheless accessible by many parties. The reason to keep things quiet, even from investors in this case, is so that no one finds out this drug works for hair loss at ~3% concentration. If anyone has been following, there have been past legal issues with companies producing bimatoprost; lawsuits etc. Now that the patent has expired for .03%, many companies can make it. Allergan doesn't even have a licensed product at this concentration yet, and they may need to have one in order to protect themselves from those that would try to make it. Like I've been saying before, it would be foolish to let the word out before you have a product to market. There would be plenty others lining up to make it and sell it themselves. Chinese companies, random labs etc.

I'd say the issue is more complex if it succeeded, than if it failed. The reason she gave was "complexity of bimatoprost." The issue is pretty complex if other parties have access to mass production of this drug, and Allergan is planning to release this same drug albeit at a higher concentration. If it was a drug that wasn't in the hands of anyone else, and it succeeded, I guarantee we would've heard something by now. On the other hand, if it failed, there would be no reason to hide the results. Drugs fail FDA trials all the time.

[It's2014ComeOnAlready]

Just got off the phone with investor relations.

I informed them as a shareholder, I have a statutory right to their records, etc. They said that they have not released the results yet, even to shareholders. I am guessing they were talking about releasing results on Investor Day which took place on February 18th. When I asked WHEN they would release the results, the woman said in a few months. I asked why it is taking so long since another product's Phase II trial (Actavis/Allergan) was completed in March and results posted in April. She said it was because of the complexity of Bimatoprost.

This is at least good news in the sense that they will be posting results.

Interesting...the complexity of bimatoprost. I wonder what that even means.

It really could be good or bad. It's nearly impossible to tell. Guess we'll have to wait.

Thanks Biqqie for looking into this!

[BiqqieSmalls]

Just got off the phone with investor relations.

I informed them as a shareholder, I have a statutory right to their records, etc. They said that they have not released the results yet, even to shareholders. I am guessing they were talking about releasing results on Investor Day which took place on February 18th. When I asked WHEN they would release the results, the woman said in a few months. I asked why it is taking so long since another product's Phase II trial (Actavis/Allergan) was completed in March and results posted in April. She said it was because of the complexity of Bimatoprost.

This is at least good news in the sense that they will be posting results.

[champpy]

Hey Hellhouser, haven't heard from you on the RU threads. Was just hoping if you can tell me if your still on RU and hows it working if you are. Don't mean to derail this thread, just trying to catch the fella while hes here

[Keki]

Yeah go biqqui you are the only who can succeed at this point, tell them you want to know just if they want to continue that direction or not, we don't care about the exact data

[It's2014ComeOnAlready]

FearTheLoss stated in the following thread (https://www.baldtruthtalk.com/showth...-trial!/page30) that Allergen wouldn't post results until 2016. Where did he come up with this information?

I am in talks with investor relations. It is their fiduciary responsibility to inform me, or anyone else who is a shareholder, how the trial went. If they don't, they're violating the the stockholder's statutory right to inspect corporate books and records.

Someone posted in a related thread they emailed allergan, and that their response was that they wouldn't post results until 2016. They are obligated by the FDA to post trial results within a year of the trial completion date.

They've had problems in the past with other companies making money off bim, maybe they don't want to have a similar situation with hair loss, since they can't yet market it? It's just a higher concentration of the drug. I don't know. It's either that or they want enough time to pass, and have other drugs be approved in the meantime, so it soften's the blow of a hyped up failure. Hope it's not the latter.

[BiqqieSmalls]

FearTheLoss stated in the following thread (https://www.baldtruthtalk.com/showth...-trial!/page30) that Allergen wouldn't post results until 2016. Where did he come up with this information?

I am in talks with investor relations. It is their fiduciary responsibility to inform me, or anyone else who is a shareholder, how the trial went. If they don't, they're violating the the stockholder's statutory right to inspect corporate books and records.

[It's2014ComeOnAlready]

BTW this is the pdf of february http://phx.corporate-ir.net/External...RJRD01Njk5MDk=

At this point, we can only speculate as to why we haven't heard anything about this drug, or why we're not allowed the information yet. It's really puzzling, but the default response will always be "it failed." That's because we're on a hair loss forum, and it's been almost 20 years since a new treatment has been approved.

[BiqqieSmalls]

Nobody contact them ... Please!

I am working on it. If other people start emailing / calling them, it is going to dilute my case! Hang tight. Just spoke with investor relations. The idiot refused to tell me anything .. After telling her that is a disservice to a shareholder, she took down my name and number promising to dig deeper into this. If I don't receive a call back by Thursday, May 7th, I will follow up.

Maybe the results did suck, but we just don't know.

[Keki]

BTW this is the pdf of february http://phx.corporate-ir.net/External...RJRD01Njk5MDk=

[Keki]

I have to agree...at this point, and with these circumstances, it's not looking good for bim. It works, we know that, just maybe not well enough to make it distinguishable from minox. However, it ain't over until the fat lady sings.

well they are completly wrong, many people there hate minox and bim even if work less effective WORKS, it's another weapon we could have i will be really pissed off if they stop bim and we will have only minox for the next 500 years with his shedding his retard cycle and his fake healthy hairs, **** minox

we should really send hundreads of mail, we need to do what we can and show interest even if it's less effective then minox, maybe they will wake up